KEY FINDINGS
The Asia-Pacific hormone replacement therapy market is predicted to record a CAGR of 8.36% during the forecast period, 2021-2028. The surging geriatric population is a dominant factor propelling the growth of the market in the region.
MARKET INSIGHTS
Vietnam, Thailand, Australia & New Zealand, India, Japan, China, Indonesia, South Korea, and Rest of Asia-Pacific, are assessed for the Asia-Pacific hormone replacement therapy market growth analysis. In Japan, a smaller therapeutic dose is preferred than in the US, leading to inadequate treatment. With changing doses and emphasis on early detection, the market is set to witness ample growth opportunities. In 2009, the Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health formulated the Guidelines for Hormone Replacement Therapy, which was revised in 2012. It aimed at organizing perceptions about HRT and enabling people to receive HRT with a sense of security.
Testosterone, estradiol, estrogen, estriol, and progesterone are hormones used in bioidentical hormone replacement therapy in Indonesia. The availability of HRT centers in the country is estimated to boost the market growth in Indonesia. According to an article, Androgel is the most common testosterone therapy drug. In countries like Malaysia, Bangladesh, and Bhutan, the growing awareness levels and the increasing focus of healthcare providers on eliminating hormonal deficiencies are projected to enable market growth. The rising demand for hormone replacement to treat dwarfism advances in drug delivery techniques and postmenopausal conditions in women further facilitate market growth in these countries.
COMPETITIVE INSIGHTS
Some of the leading market players include Viatris Inc (Mylan NV), Novo Nordisk A/S, Noven Pharmaceuticals Inc, Pfizer Inc, Novartis AG, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments